These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24853292)

  • 1. Exercise-induced pulse wave velocity changes in untreated patients with essential hypertension: the effect of an angiotensin receptor antagonist.
    Gkaliagkousi E; Gavriilaki E; Nikolaidou B; Triantafyllou G; Douma S
    J Clin Hypertens (Greenwich); 2014 Jul; 16(7):482-7. PubMed ID: 24853292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.
    Gkaliagkousi E; Gavriilaki E; Yiannaki E; Markala D; Papadopoulos N; Triantafyllou A; Anyfanti P; Petidis K; Garypidou V; Doumas M; Ferro A; Douma S
    Am J Hypertens; 2014 Apr; 27(4):571-8. PubMed ID: 23975222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.
    Georgianos PI; Sarafidis PA; Zebekakis PE
    J Clin Hypertens (Greenwich); 2014 Jul; 16(7):475-6. PubMed ID: 24837170
    [No Abstract]   [Full Text] [Related]  

  • 4. Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.
    Phillips AA
    J Clin Hypertens (Greenwich); 2014 Oct; 16(10):768. PubMed ID: 25131987
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to: Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.
    Gkaliagkousi E; Gavriilaki E; Douma S
    J Clin Hypertens (Greenwich); 2014 Oct; 16(10):769. PubMed ID: 25098956
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
    Mahmud A; Feely J
    J Hum Hypertens; 2000 Sep; 14(9):541-6. PubMed ID: 10980584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.
    Hayoz D; Zappe DH; Meyer MA; Baek I; Kandra A; Joly MP; Mazzolai L; Haesler E; Periard D
    J Clin Hypertens (Greenwich); 2012 Nov; 14(11):773-8. PubMed ID: 23126349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
    Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
    Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
    Anan F; Takahashi N; Ooie T; Yufu K; Hara M; Nakagawa M; Yonemochi H; Saikawa T; Yoshimatsu H
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):353-9. PubMed ID: 15918057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure.
    Boutouyrie P; Beaussier H; Achouba A; Laurent S;
    J Hypertens; 2014 Jan; 32(1):108-14. PubMed ID: 24275838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients.
    Takami T; Shigemasa M
    Hypertens Res; 2003 Aug; 26(8):609-14. PubMed ID: 14567499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
    Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
    Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness.
    Suzuki H; Nakamoto H; Okada H; Sugahara S; Kanno Y
    Adv Perit Dial; 2003; 19():59-66. PubMed ID: 14763035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension.
    Okura T; Watanabe S; Kurata M; Koresawa M; Irita J; Enomoto D; Jotoku M; Miyoshi K; Fukuoka T; Higaki J
    Clin Exp Hypertens; 2008 Jul; 30(5):415-22. PubMed ID: 18633763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study.
    Spanos G; Kalaitzidis R; Karasavvidou D; Pappas K; Siamopoulos KC
    J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):315-21. PubMed ID: 23132848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuable lessons from VALUE.
    Hedner T; Kjeldsen SE; Himmelmann A
    Blood Press; 2004; 13(4):196-7. PubMed ID: 15581332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.